LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 869-874

  Kitkumthorn, Nakarin ^a   Tuangsintanakul, Time ^b,c   Rattanatanyong, Prakasit ^b   Tiwawech, Danai ^c   Mutirangura, Apiwat ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Cancer; COBRA LINE 1; Level and pattern; LINE 1 methylation; Peripheral blood mononuclear cells

Indexed keywords

AGED; ARTICLE; BILE DUCT CANCER; CANCER DIAGNOSIS; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METHYLATION; NASOPHARYNX CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THAILAND;

ADULT; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858614329     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.024     Document Type: Article

References (35)

1. Piyathilake C.J., Frost A.R., Bell W.C., et al. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol 2001, 32:856-862.
2. Hoffmann M.J., Schulz W.A. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 2005, 83:296-321.
3. Mutirangura A. Quantitative PCR analysis for methylation level of genome: clinical implications in cancer. Asian Biomed 2007, 1:121-128.
4. Yang A.S., Estecio M.R., Doshi K., et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004, 32:e38.
5. Weisenberger D.J., Campan M., Long T.I., et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005, 33:6823-6836.
6. Kazazian H.H., Moran J.V. The impact of L1 retrotransposons on the human genome. Nat Genet 1998, 19:19-24.
7. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
8. Kitkumthorn N., Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical application. Clin Epigenet 2011, 2:315-330.
9. Chalitchagorn K., Shuangshoti S., Hourpai N., et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004, 23:8841-8846.
10. Pornthanakasem W., Kongruttanachok N., Phuangphairoj C., et al. LINE-1 methylation status of endogenous DNA double-strand breaks. Nucleic Acids Res 2008, 36:3667-3675.
11. Schulz W.A., Elo J.P., Florl A.R., et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 2002, 35:58-65.
12. Choi I.S., Estecio M.R., Nagano Y., et al. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol 2007, 20:802-810.
13. Bollati V., Fabris S., Pegoraro V., et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis 2009, 30:1330-1335.
14. Kongruttanachok N., Phuangphairoj C., Thongnak A., et al. Replication independent DNA double-strand break retention may prevent genomic instability. Mol Cancer 2010, 9:70.
15. Kim B.H., Cho N.Y., Shin S.H., et al. CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma. Virchows Arch 2009, 455:343-351.
16. Wolff E.M., Byun H.M., Han H.F., et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 2010, 6:e1000917.
17. Aporntewan C., Phokaew C., Piriyapongsa J., et al. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PLoS One 2011, 6:e17934.
18. Woloszynska-Read A., Mhawech-Fauceglia P., Yu J., et al. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clin Cancer Res 2008, 14:3283-3290.
19. Vlassov V.V., Laktionov P.P., Rykova E.Y. Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med 2010, 10:142-165.
20. Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011, 11:426-437.
21. Kohler C., Barekati Z., Radpour R., et al. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 2011, 31:2623-2628.
22. Hsiung D.T., Marsit C.J., Houseman E.A., et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007, 16:108-114.
23. Pobsook T., Subbalekha K., Sannikorn P., et al. Improved measurement of LINE-1 sequence methylation for cancer detection. Clin Chim Acta 2011, 412:314-321.
24. Hou L., Wang H., Sartori S., et al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer 2010, 127:1866-1874.
25. Wilhelm C.S., Kelsey K.T., Butler R., et al. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010, 16:1682-1689.
26. Liao L.M., Brennan P., van Bemmel D.M., et al. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One 2011, 6:e27361.
27. Phokaew C., Kowudtitham S., Subbalekha K., et al. LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic Acids Res 2008, 36:5704-5712.
28. Moore L.E., Pfeiffer R.M., Poscablo C., et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008, 9:359-366.
29. Piyathilake C.J., Macaluso M., Alvarez R.D., et al. A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasia. Nutrition 2011, 27:513-519.
30. Lee J.J., Geli J., Larsson C., et al. Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer. Int J Oncol 2008, 33:861-869.
31. Choi S.H., Worswick S., Byun H.M., et al. Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int J Cancer 2009, 125:723-729.
32. Juhlin C.C., Kiss N.B., Villablanca A., et al. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS One 2010, 5:e9472.
33. Figueiredo J.C., Grau M.V., Wallace K., et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009, 18:1041-10499.
34. Hillemacher T., Frieling H., Moskau S., et al. Global DNA methylation is influenced by smoking behaviour. Eur Neuropsychopharmacol 2008, 18:295-298.
35. Madrigano J., Baccarelli A., Mittleman M.A., et al. Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ Health Perspect 2011, 119:977-982.